HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,166,853 | -17.2% | 6,958,110 | -6.7% | 0.00% | 0.0% |
| Q2 2023 | $8,651,341 | -51.7% | 7,458,052 | -37.2% | 0.00% | -55.6% |
| Q1 2023 | $17,923,844 | -39.6% | 11,870,096 | +0.0% | 0.01% | -40.0% |
| Q4 2022 | $29,669,450 | -40.8% | 11,867,780 | -0.1% | 0.02% | -44.4% |
| Q3 2022 | $50,146,000 | +51.9% | 11,883,178 | +0.4% | 0.03% | +68.8% |
| Q2 2022 | $33,010,000 | -51.4% | 11,831,524 | -0.4% | 0.02% | -40.7% |
| Q1 2022 | $67,946,000 | -37.8% | 11,878,576 | -0.7% | 0.03% | -30.8% |
| Q4 2021 | $109,263,000 | -14.7% | 11,967,465 | -0.1% | 0.04% | -18.8% |
| Q3 2021 | $128,071,000 | -37.8% | 11,980,462 | -9.7% | 0.05% | -39.2% |
| Q2 2021 | $205,930,000 | +0.4% | 13,268,720 | +4.9% | 0.08% | -4.8% |
| Q1 2021 | $205,039,000 | -23.7% | 12,648,894 | -0.3% | 0.08% | -27.2% |
| Q4 2020 | $268,556,000 | +40.6% | 12,688,702 | -1.5% | 0.11% | +23.9% |
| Q3 2020 | $190,946,000 | -11.5% | 12,884,364 | +2.5% | 0.09% | -17.1% |
| Q2 2020 | $215,746,000 | +44.2% | 12,565,308 | -1.4% | 0.11% | +11.0% |
| Q1 2020 | $149,588,000 | -48.5% | 12,742,271 | +3.1% | 0.10% | -34.6% |
| Q4 2019 | $290,496,000 | +51.9% | 12,361,411 | +19.6% | 0.15% | +47.1% |
| Q3 2019 | $191,257,000 | +10.3% | 10,335,031 | +10.8% | 0.10% | +13.0% |
| Q2 2019 | $173,355,000 | -17.3% | 9,325,527 | +8.7% | 0.09% | -17.9% |
| Q1 2019 | $209,635,000 | -4.0% | 8,578,877 | +1.9% | 0.11% | -15.2% |
| Q4 2018 | $218,356,000 | +17.8% | 8,421,291 | +43.8% | 0.13% | +43.5% |
| Q3 2018 | $185,409,000 | -19.8% | 5,858,276 | -1.5% | 0.09% | -22.7% |
| Q2 2018 | $231,097,000 | +18.9% | 5,946,999 | -15.6% | 0.12% | +20.2% |
| Q1 2018 | $194,385,000 | +31.0% | 7,042,893 | -14.1% | 0.10% | +39.4% |
| Q4 2017 | $148,357,000 | +9.1% | 8,195,703 | -2.7% | 0.07% | +6.0% |
| Q3 2017 | $136,030,000 | +17.2% | 8,423,177 | +0.5% | 0.07% | +15.5% |
| Q2 2017 | $116,029,000 | -8.5% | 8,377,589 | -0.9% | 0.06% | -9.4% |
| Q1 2017 | $126,802,000 | +26.0% | 8,453,095 | +10.0% | 0.06% | +23.1% |
| Q4 2016 | $100,669,000 | -24.5% | 7,685,568 | -0.6% | 0.05% | -25.7% |
| Q3 2016 | $133,283,000 | -4.8% | 7,735,848 | -0.2% | 0.07% | -6.7% |
| Q2 2016 | $139,937,000 | -2.1% | 7,752,460 | +3.0% | 0.08% | -1.3% |
| Q1 2016 | $142,869,000 | -8.8% | 7,523,278 | +28.2% | 0.08% | -3.8% |
| Q4 2015 | $156,737,000 | +10.1% | 5,870,270 | +0.6% | 0.08% | +12.9% |
| Q3 2015 | $142,378,000 | -28.1% | 5,835,140 | -8.2% | 0.07% | -22.2% |
| Q2 2015 | $198,093,000 | +172.0% | 6,357,294 | +27.0% | 0.09% | +172.7% |
| Q1 2015 | $72,833,000 | +62.2% | 5,005,678 | +12.1% | 0.03% | +65.0% |
| Q4 2014 | $44,917,000 | +27.7% | 4,464,938 | +5.7% | 0.02% | +25.0% |
| Q3 2014 | $35,179,000 | -22.4% | 4,223,152 | +14.7% | 0.02% | -20.0% |
| Q2 2014 | $45,345,000 | +0.3% | 3,680,581 | +13.2% | 0.02% | -4.8% |
| Q1 2014 | $45,226,000 | – | 3,251,353 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |